Allergic Rhinitis Market Forecast 2024-2033: Projected CAGR, Key Drivers, And Trends|Merck and Co. Inc., Bayer AG, Novartis AG, Sanofi-Aventis LLC., AstraZeneca PLC

The allergic rhinitis market size is expected to see steady growth in the next few years. It will grow to $17.62 billion in 2028 at a compound annual growth rate (CAGR) of 3.7%. The growth in the forecast period can be attributed to demand for preventive treatments, aging population, urbanization, health care spending. Major trends in the forecast period include biologics and monoclonal antibodies, digital health solutions, allergen avoidance strategies, pediatric allergic rhinitis, allergen detection technology.

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/allergic-rhinitis-global-market-report

Segmentation & Regional Insights
The allergic rhinitis market covered in this report is segmented –

1) By Type: Seasonal Allergic Rhinitis; Perennial Allergic Rhinitis; Occupational Allergic Rhinitis
2) By Treatment: Antihistamines; Corticosteroids; Immunotherapy; Decongestants; Other Treatments
3) By Test: Skin Test; IgE Radioallergosorbent (RAST) Test; Complete Blood Count
4) By Route Of Administration: Oral; Nasal; Other Route Of Administration
5) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Stores

North America was the largest region in the allergic rhinitis market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in allergic rhinitis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12926&type=smp

Major Driver Impacting Market Growth
High levels of air pollution and climate change are expected to propel the growth of the allergic rhinitis market going forward. Air pollution refers to the presence of harmful substances in the Earth’s atmosphere that can adversely affect human health, the environment and the quality of the air we breathe. Climate change refers to long-term alterations in the Earth’s climate patterns, including temperature, precipitation and other climatic factors. Air pollution has been increasingly recognized as a significant environmental factor contributing to the prevalence and worsening of allergic rhinitis, highlighting the intricate relationship between air quality and respiratory health. For instance, in September 2022, according to the World Bank, a US-based financial institution, it was estimated that the cost of the health damage caused by air pollution would amount to $8.1 trillion a year, equivalent to 6.1% of global GDP. Therefore, high levels of air pollution and climate change drive the allergic rhinitis market.

Key Industry Players
Major players in the allergic rhinitis market are Merck and Co. Inc., Bayer AG, Novartis AG, Sanofi-Aventis LLC., AstraZeneca PLC, GlaxoSmithKline plc., Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., UCB S.A., Sun Pharmaceutical Industries Limited, Menarini Group, Perrigo Company PLC, Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals PLC, Cipla Limited, Endo Pharmaceuticals Inc., Zydus Lifesciences Ltd., Lupin Limited, Glenmark Pharma Ltd., Almirall S.A., Kyowa Kirin Co. Ltd., Hanmi Pharmaceutical Co. Ltd., Akorn Inc.

The allergic rhinitis market report table of contents includes:

1. Executive Summary
2. Allergic Rhinitis Market Characteristics
3. Allergic Rhinitis Market Trends And Strategies
4. Allergic Rhinitis Market – Macro Economic Scenario
5. Global      Allergic Rhinitis Market Size and Growth

.

.

.

32. Global      Allergic Rhinitis Market Competitive Benchmarking
33. Global      Allergic Rhinitis Market Competitive Dashboard
34. Key Mergers And Acquisitions In      Allergic Rhinitis Market
35. Allergic Rhinitis Market Future Outlook and Potential Analysis
36. Appendix

 

Top Major Players :

• Merck and Co. Inc.
• Bayer AG
• Novartis AG
• Sanofi-Aventis LLC.
• AstraZeneca PLC

Explore the trending research reports from TBRC:

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model